GBR 830
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GBR 830, covering 2020-05-18 to 2020-05-18. Get the full timeline:
Most recent: Clinical Trial Update: To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis [Phase 2]